Vor Biopharma (VOR) Stock Statistics & Valuation Metrics

Vor Biopharma has a market cap or net worth of $1.38B. The enterprise value is $536.49.

Vor Biopharma has 59,162,292 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vor Biopharma’s return on equity (ROE) is 4.24 and return on invested capital (ROIC) is -84.61%.

The current PE Ratio of Vor Biopharma is ―. Vor Biopharma’s PEG ratio is -0.00173.

In the last 12 months, Vor Biopharma had revenue of 0.00 and earned -695.98M in profits. Earnings per share was -70.50.

In the last 12 months, operating cash flow was -140.38M and capital expenditures -726.00K, giving a free cash flow of -141.11M billion.

Vor Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Vor Biopharma upcoming earnings date is Nov 11, 2026, Before Open (Confirmed).

Vor Biopharma as a current ratio of 18.20, with Debt / Equity ratio of -1.44%

In the past 12 months, Vor Biopharma has paid 0.00 in taxes.

Vor Biopharma EV to EBITDA ratio is 0.38, with an EV/FCF ratio of 1.84.

Vor Biopharma has $466.13M in cash and marketable securities with $2.88M in debt, giving a net cash position of $463.25M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Vor Biopharma is $34.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy